317450 — Myung In Pharm Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapContrarian

Annual balance sheet for Myung In Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	142,839	183,475	260,247	487,792
Net Total Accounts Receivable
Net Total Receivables	59,493	62,020	64,433	68,870
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	250,818	307,589	385,809	643,309
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	103,706	99,309	99,259	118,513
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	471,556	521,590	581,692	841,675
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	35,093	39,184	44,602	46,184
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	47,577	49,276	49,871	47,297
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	423,979	472,314	531,821	794,378
Total Liabilities & Shareholders' Equity	471,556	521,590	581,692	841,675
Total Common Shares Outstanding